For the Inventor, By the Inventor

Enter assignee name

Bothell, WA, United States of America

Pharmain Corporation

Calculating rank

USPTO Granted Patents = 20

% Expired Patents = 10.0

CIPO Patents = 4

EPO Patents = 6

Forward Citations = 230

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Elijah M Bolotin (18 out of 24 patents)

Gerardo M Castillo (17 out of 54 patents)

Akiko Nishimoto-Ashfield (3 out of 3 patents)

4. Akiko Nashimoto-Ashfield (2 out of 2 patents)

5. Cynthia C Jones (1 out of 2 patents)

6. Joshua F Alfaro (1 out of 2 patents)

7. Alexei A Bogdanov (1 out of 14 patents)

8. Elaine K Chan (1 out of 1 patent)

9. Yao Yao (1 out of 1 patent)

10. Christian Ventocilla (1 out of 1 patent)

11. Han Jiang (1 out of 1 patent)

12. Ellijah M Bolotin (1 out of 1 patent)

13. Elijah M Bolitin (0 patent)

20 patents: Sort by Forward Citations

1. 12679877 - NPRA AGONISTS, COMPOSITIONS, AND USES THEREOF (2026-07-14),

2. RE50618 - Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same (2025-10-07),

3. 12410211 - V1A receptor partial agonist and method of use (2025-09-09),

4. 10624966 - Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same (2020-04-21),

5. 10507248 - Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same (2019-12-17),

6. 10035885 - Method of production of graft co-polymer excipient with a superior peptide and protein binding property (2018-07-31),

7. 10010613 - Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same (2018-07-03),

8. 9657078 - Composition for long-acting peptide analogs (2017-05-23),

9. 9562111 - Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same (2017-02-07),

10. 9090664 - Composition for long-acting peptide analogs (2015-07-28),

11. 8999930 - Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same (2015-04-07),

12. 8563527 - Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same (2013-10-22),

13. 8277776 - Compositions for delivery of therapeutics and other materials (2012-10-02),

14. 8257682 - Compositions for delivery of therapeutics and other materials (2012-09-04),

15. 8231859 - Compositions for delivery of therapeutics and other materials (2012-07-31),

Company Overview

Pharmain Corporation, based in Bothell, WA, specializes in the development and manufacturing of innovative pharmaceutical products. The company focuses on advanced drug delivery systems and formulations, aiming to enhance therapeutic efficacy and patient compliance. With a commitment to research and development, Pharmain leverages cutting-edge technologies to address unmet medical needs across various therapeutic areas. Its strategic location in the Pacific Northwest positions it within a vibrant biotech ecosystem, fostering collaboration and innovation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

20 Patents

#29 in Bothell, WA

#356 in Washington

#16,416 in US

#31,315 in the World

Bothell, WA, United States of America

Pharmain Corporation

Forward Citations = 230

11 inventors:

Elijah M Bolotin (18 out of 24 patents)

Gerardo M Castillo (17 out of 54 patents)

Akiko Nishimoto-Ashfield (3 out of 3 patents)

4. Akiko Nashimoto-Ashfield (2 out of 2 patents)

5. Cynthia C Jones (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharmain Corporation. Retrieved from https://idiyas.com/company/pharmain

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…